沃森生物：公司在合成生物领域、微生态健康领域的布局已进入实际实施阶段

Group 1 - The company Watson Bio (300142.SZ) has stated on February 5 that information regarding its external investment and mergers should be based on the announcements disclosed by the company [2] - The company's layout in the fields of synthetic biology and micro-ecological health has entered the actual implementation stage [2] - Stakeholders are encouraged to pay attention to the company's information disclosure regarding the progress of products and projects in 2026 [2]